The COVID-19 pandemic continues to rage over the world, with certain nations, such as India, seeing unprecedented levels of infection, wreaking havoc on population health as well as social and economic well-being. In other parts of the world, significant progress has been made in controlling the disease, most notably in Israel, where about 60% of the population has received two vaccinations. The creation and production of vaccinations is a stunning display of medical and technological progress. Vaccines have a unique market in a number of ways that set it distinct from other sectors.
Title : Multidrug resistance in burn patients
Dimple Sethi Chopra, Punjabi University, India
Title : CRISPR/Cas12a-powered ultrasensitive immunosensing for the detection of single microorganisms
Fei Deng, University of New South Wales, Australia
Title : Interpretation of non-responders to SARS CoV 2 vaccines using WHO International Standard
Xu Yang, Shanghai University of Medicine and Health Sciences, China
Title : COVID 19 pandemic; a complex mixture of co-infection and comorbidity
Hem Chandra Jha, Indian Institute of Technology Indore, India
Title : O GlcNAcylation enhances sensitivity to RSL3 induced ferroptosis via the YAP TFRC pathway in liver cancer
Abduh Murshed, Tongji University, China
Title : Applications of Artificial Intelligence in Clinical Microbiology Diagnostic Testing
P Hema Prakash Kumari, GITAM Institute of Medical Sciences and Research, India